NCT07305259 2025-12-26
REACT
Florida State University
Phase EARLY_PHASE1 Recruiting
Clinical Trials
10 trialsNCT04513028 2025-10-30
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
University of Louisville
Phase NA Recruiting
NCT00682032 2025-01-10
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
University of Louisville
Phase NA Recruiting
NCT00492167 2022-03-07
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT04710290 2021-01-25
A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
E-DA Hospital
Phase 2/3 Unknown
NCT00290407 2018-05-04
Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
University of Louisville
Phase 2 Terminated
NCT01829373 2013-04-11
Lung Cancer Vaccine Plus Oral Dietary Supplement
University of Kentucky
Phase 1 Completed
NCT00087009 2013-03-19
Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
Memorial Sloan Kettering Cancer Center
Phase 1 Terminated
NCT00037011 2013-01-18
Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00089258 2013-01-17
Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Completed